Oncorus
Spencer is a Managing Partner at KSV Global where he focuses on novel technologies and therapeutics in healthcare. Prior to joining KSV Global, Spencer was a senior research fellow at the Christensen Institute for Disruptive Innovation where he researched disruptive innovation models in healthcare.
Prior to Christensen Institute, Spencer spent 10 years as a licensed securities analyst on Wall Street where he had research coverage on medical devices, diagnostics and life science tools companies.
Before Wall Street, Spencer was a consultant at Bain & Company where he advised senior management teams of Fortune 500 companies. Spencer holds AB in Mathematics from Harvard College and an MBA from Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Oncorus
Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of the immune system to treat solid tumors.